Advertisement
Canada markets close in 5 hours 13 minutes
  • S&P/TSX

    21,746.35
    -127.37 (-0.58%)
     
  • S&P 500

    5,003.72
    -67.91 (-1.34%)
     
  • DOW

    37,779.45
    -681.47 (-1.77%)
     
  • CAD/USD

    0.7299
    +0.0001 (+0.02%)
     
  • CRUDE OIL

    82.27
    -0.54 (-0.65%)
     
  • Bitcoin CAD

    87,011.42
    -1,891.80 (-2.13%)
     
  • CMC Crypto 200

    1,377.67
    -4.91 (-0.35%)
     
  • GOLD FUTURES

    2,353.10
    +14.70 (+0.63%)
     
  • RUSSELL 2000

    1,969.14
    -26.29 (-1.32%)
     
  • 10-Yr Bond

    4.7100
    +0.0580 (+1.25%)
     
  • NASDAQ

    15,450.21
    -262.54 (-1.67%)
     
  • VOLATILITY

    16.82
    +0.85 (+5.33%)
     
  • FTSE

    8,067.95
    +27.57 (+0.34%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6807
    -0.0012 (-0.18%)
     

Stocks in play: PharmaTher Inc

Is pleased to provide an update on the Company’s psilocybin pharmaceutical development programs. The Company is evaluating psilocybin as a potential treatment for methamphetamine use disorder with the University of Wisconsin-Madison through a clinical trial agreement. PharmaTher Inc shares C.PHRM are trading unchanged at $0.34.

Read: